Evidence map›Paper›PMID 33218212›Full record

ArticleJournal of clinical medicine2020

Longitudinal Imaging Using PET/CT with Collagen-I PET-Tracer and MRI for Assessment of Fibrotic and Inflammatory Lesions in a Rat Lung Injury Model.

Irma Mahmutovic Persson, Nina Fransén Pettersson, Jian Liu, Hanna Falk Håkansson, Anders Örbom, René In 't Zandt, Ritha Gidlöf, Marie Sydoff, Karin von Wachenfeldt, Lars E Olsson

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Pulmonary Fibrosis-Focusing on the Future: Aspen Lung Conference 2024 Summary.American journal of respiratory cell and molecular biology · 2025
    Article
  3. Article
  4. Review
  5. Imaging technologies in experimental pulmonary fibrosis research: essential tool for enhanced translational relevance.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. Frontiers in medicine · 2025
    Article
  7. [European journal of nuclear medicine and molecular imaging · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Frontiers in medicine · 2024
    Article
  12. Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  13. Utilizing MRI, [Frontiers in nuclear medicine · 2023
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Irma Mahmutovic PerssonDepartment of Medical Radiation Physics, Institution of Translational Medicine, Faculty of Medicine, Lund University, 20502 Malmö, Sweden.ORCID 0000-0001-5959-3777
Nina Fransén PetterssonTruly Labs, Medicon Village, 223 63 Lund, Sweden.ORCID 0000-0002-5049-1544
Jian LiuTruly Labs, Medicon Village, 223 63 Lund, Sweden.
Hanna Falk HåkanssonTruly Labs, Medicon Village, 223 63 Lund, Sweden.
Anders ÖrbomDepartment of Oncology and Pathology, Clinical Sciences, Lund University, 22184 84 Lund, Sweden.
René In 't ZandtLund University BioImaging Centre, Faculty of Medicine, Lund University, 221 42 Lund, Sweden.
Ritha GidlöfLund University BioImaging Centre, Faculty of Medicine, Lund University, 221 42 Lund, Sweden.
Marie SydoffLund University BioImaging Centre, Faculty of Medicine, Lund University, 221 42 Lund, Sweden.ORCID 0000-0001-6895-0414
Karin von WachenfeldtTruly Labs, Medicon Village, 223 63 Lund, Sweden.ORCID 0000-0003-0579-2484
Lars E OlssonDepartment of Medical Radiation Physics, Institution of Translational Medicine, Faculty of Medicine, Lund University, 20502 Malmö, Sweden.ORCID 0000-0001-6090-6697

Funding

Innovative Medicines Initiative IB4SD-116106
6 · The paper itself

Abstract

Non-invasive imaging biomarkers (IBs) are warranted to enable improved diagnostics and follow-up monitoring of interstitial lung disease (ILD) including drug-induced ILD (DIILD). Of special interest are IB, which can characterize and differentiate acute inflammation from fibrosis. The aim of the present study was to evaluate a PET-tracer specific for Collagen-I, combined with multi-echo MRI, in a rat model of DIILD. Rats were challenged intratracheally with bleomycin, and subsequently followed by MRI and PET/CT for four weeks. PET imaging demonstrated a significantly increased uptake of the collagen tracer in the lungs of challenged rats compared to controls. This was confirmed by MRI characterization of the lesions as edema or fibrotic tissue. The uptake of tracer did not show complete spatial overlap with the lesions identified by MRI. Instead, the tracer signal appeared at the borderline between lesion and healthy tissue. Histological tissue staining, fibrosis scoring, lysyl oxidase activity measurements, and gene expression markers all confirmed establishing fibrosis over time. In conclusion, the novel PET tracer for Collagen-I combined with multi-echo MRI, were successfully able to monitor fibrotic changes in bleomycin-induced lung injury. The translational approach of using non-invasive imaging techniques show potential also from a clinical perspective.

Indexed as

animal modelbleomycinCollagen-Idrug-induced interstitial lung disease (DIILD)drug toxicityfibrosisinterstitial lung disease (ILD)lung imagingmagnetic resonance imaging (MRI)positron emission tomography (PET)

Identifiers

PMID33218212
PMCPMC7699272

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.